Table 1—

Characteristics of the study populations

RegionCountryCenternKnown diabetes (%)SDM (%)Age rangeStudy period
GreenlandGreenlandB99*1,1421.19.127–861998–2002
North EuropeU.K.Ely*1,1567.040–691990–1992
NHP*8002.67.630–761992–1994
Whitehall II10,2700.81.539–631991–1993
FinlandEast-West Finland*46112.410.870–891989
FIN–MONICA921,9294.63.940–641992
Vantaa*61311.36.464–661990–1991
FINRISK02*3,7673.38.844–752002
SwedenNSW–MONICA3,5616.82.825–751986–2004
ULSAM*1,2215.710.369–741991–1995
DenmarkGlostrup*6955.63.759–621996–1997
Inter99*6,7842.03.930–601999–2001
GermanyKORA*1,4858.88.055–741999–2001
Central EuropeHollandHoorn*2,4843.56.649–771989–1991
Zutphen*4848.19.770–901990
FranceParis Prospective*7,1762.04.344–551968–1974
PolandPMSDE*2,8386.37.835–771998–2000
South EuropeSpainGuia*6938.99.730–931994–1997
IsraelGOH*1,2911.97.335–691976–1982
Eastern Mediterranean and Middle EastEgyptEgypt*1,45128.59.320–891992–1993
AfricaMauritiusMauritius*4,9086.18.425–751987
CameroonCameroon*1,8040.40.724–741996
IndiaIndiaCUPS*1,2597.14.820–871996–1998
Dombivli5505.58.531–801998–1999
Chennai2,1827.56.418–941993–1995
CURES*2,3506.19.720+2001–2004
JapanJapanFunagata*2,1545.13.535–891992–1997
Asia remainingChinaHarbin1,3761.52.040–851998
Qingdao2,0614.79.330–742002
IndonesiaJakarta*1,0193.54.314–871992–1993
TaiwanKinmen*1,45612.630–881991–1994
SingaporeNHS92*3,5684.46.017–691992
KoreaKorea10,0445.77.337–712001–2003
VietnamVietnam*9,1221.22.330–652002
Australia and New ZealandAustraliaAusDiab*11,1445.14.225–951999–2000
Pacific IslandsNauruNauru*86819.114.719–811987
TongaTonga*47215.015–851998–2000
Tonga04*1,0169.315–872001–2004
SamoaSamoa*3,2853.87.520–901978–1991
North AmericaU.S.NHANES III*3,1057.19.940–741988–1994
NHANES II*3,8142.65.620–741976–1980
ARIC, U.S.*11,59611.810.052–701996–1999
NHANES99*5,9294.82.612–851999–2001
  • *

    * Centers with measured fasting plasma glucose in individuals with known diabetes.

  • Centers with measured 2-h plasma glucose in individuals with known diabetes.

  • ‡In NHANES99, SDM is based on fasting values only. ARIC, Atherosclerosis Risk in Communities; AusDiab, Australian Diabetes, Obesity and Lifestyle Study; CUPS, Chennai Urban Population Study; CURES, Chennai Urban Rural Epidemiology Study; FIN-MONICA, Finland Monitoring of Trends and Determinants in Cardiovascular Disease; GOH, Glucose Intolerance Obesity and Hypertension; FINRISK02, FINRISK 2002; KORA, Cooperative Health Research in the Region of Augsburg; NHANES, National Health and Nutrition Examination Survey; NHS92, 1992 National Health Survey; NHP, Newcastle Heart Project; NSW-MONICA, New South Wales Monitoring of Trends and Determinants in Cardiovascular Disease; PMSDE, Polish Multicenter Study on Diabetes Epidemiology; ULSAM, Longitudinal Study of Adult Men.